Indications
VidPrevtyn Beta is indicated as a booster for active immunisation to prevent COVID-19 in adults who have previously received an mRNA or adenoviral vector COVID-19 vaccine (see sections 4.2 and 5.1 in product information document). The use of this vaccine should be in accordance with official recommendations.
Composition
- Active substance
- SARS-CoV-2 prefusion Spike delta TM protein, recombinant (B.1.351 strain)
- International name (INN)
- COVID-19 Vaccine (recombinant, adjuvanted)
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- VidPrevtyn Beta
- Active substance
- SARS-CoV-2 prefusion Spike delta TM protein, recombinant (B.1.351 strain)
- ATC code
- J07BN04